ScottDLeeMD
Gastroenterology • Seattle, WAAssociate Professor, Medicine, University of Washington School of Medicine
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4377Fax+1 206-598-4732
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
WA State Medical License 1997 - 2025
IL State Medical License 2000 - 2002
American Board of Internal Medicine Gastroenterology
Clinical Trials
- Asacol Dosing Study for Active Ulcerative Colitis Start of enrollment: 2003 Jun 01
- Induction of Clinical Response Using Rifaximin in Crohn's Disease Start of enrollment: 2008 Nov 01
- Study of Cimzia for the Treatment of Ulcerative Colitis Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- Discordance between endoscopic and histopathologic assessment in ileal Crohn's disease.Scott D Lee, Brian Mau, Cody J Avalos, Kindra D Clark-Snustad, Kendra J Kamp
World Journal of Gastrointestinal Endoscopy. 2025-02-16 - Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry.Gary R Lichtenstein, Scott D Lee, Brian G Feagan, Edward V Loftus Jr, Samson Ng
Crohn's & Colitis 360. 2025-01-01 - 3 citationsExtended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.Geert D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, Bruce E Sands, Scott Lee
Inflammatory Bowel Diseases. 2024-12-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
